Edwin C.Y. Chow

2.2k total citations
54 papers, 1.7k citations indexed

About

Edwin C.Y. Chow is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Pathology and Forensic Medicine. According to data from OpenAlex, Edwin C.Y. Chow has authored 54 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 14 papers in Pediatrics, Perinatology and Child Health and 12 papers in Pathology and Forensic Medicine. Recurrent topics in Edwin C.Y. Chow's work include Drug Transport and Resistance Mechanisms (17 papers), Vitamin D Research Studies (12 papers) and Pharmacological Effects and Toxicity Studies (11 papers). Edwin C.Y. Chow is often cited by papers focused on Drug Transport and Resistance Mechanisms (17 papers), Vitamin D Research Studies (12 papers) and Pharmacological Effects and Toxicity Studies (11 papers). Edwin C.Y. Chow collaborates with scholars based in Canada, United States and Netherlands. Edwin C.Y. Chow's co-authors include K. Sandy Pang, Jan D. Huizinga, Matthew R. Durk, Geny M. M. Groothuis, Ansar A. Khan, Robert J. Porte, Yan Chen, Heather Whetstone, Benjamin A. Alman and Alvin C. Lin and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and Gastroenterology.

In The Last Decade

Edwin C.Y. Chow

53 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edwin C.Y. Chow Canada 25 563 411 346 319 224 54 1.7k
Liang Qiao China 27 610 1.1× 922 2.2× 149 0.4× 79 0.2× 120 0.5× 92 2.4k
Delbert G. Gillespie United States 37 432 0.8× 1.3k 3.1× 284 0.8× 176 0.6× 50 0.2× 102 3.7k
Rasmus Jansson‐Löfmark Sweden 26 187 0.3× 466 1.1× 102 0.3× 65 0.2× 161 0.7× 81 2.1k
Gabriel Frampton United States 24 495 0.9× 568 1.4× 57 0.2× 102 0.3× 129 0.6× 52 1.7k
Matthew McMillin United States 22 496 0.9× 497 1.2× 38 0.1× 118 0.4× 139 0.6× 57 1.6k
M Deschodt-Lanckman Belgium 31 550 1.0× 1.0k 2.5× 107 0.3× 85 0.3× 407 1.8× 86 2.9k
Miklós Tóth Hungary 31 492 0.9× 763 1.9× 99 0.3× 108 0.3× 47 0.2× 162 3.1k
Xueqian Wang China 22 392 0.7× 895 2.2× 66 0.2× 90 0.3× 165 0.7× 79 2.0k
Gene LeSage United States 42 1.5k 2.7× 919 2.2× 141 0.4× 209 0.7× 155 0.7× 84 4.6k

Countries citing papers authored by Edwin C.Y. Chow

Since Specialization
Citations

This map shows the geographic impact of Edwin C.Y. Chow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edwin C.Y. Chow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edwin C.Y. Chow more than expected).

Fields of papers citing papers by Edwin C.Y. Chow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edwin C.Y. Chow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edwin C.Y. Chow. The network helps show where Edwin C.Y. Chow may publish in the future.

Co-authorship network of co-authors of Edwin C.Y. Chow

This figure shows the co-authorship network connecting the top 25 collaborators of Edwin C.Y. Chow. A scholar is included among the top collaborators of Edwin C.Y. Chow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edwin C.Y. Chow. Edwin C.Y. Chow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chow, Edwin C.Y., Alexei Ionan, Shwu‐Luan Lee, et al.. (2024). FDA Approval Summary: Asciminib for Ph+ CML in Chronic Phase Treated with Two or More Tyrosine Kinase Inhibitors and for the T315I Mutation. Clinical Cancer Research. 30(19). 4266–4271. 2 indexed citations
2.
Woods, Ashley, Kelly J. Norsworthy, Jonathon Vallejo, et al.. (2023). FDA Approval Summary: Ivosidenib in Combination with Azacitidine for Treatment of Patients with Newly Diagnosed Acute Myeloid Leukemia with an IDH1 Mutation. Clinical Cancer Research. 30(7). 1226–1231. 16 indexed citations
3.
Narayan, Preeti, Christy Osgood, Harpreet Singh, et al.. (2021). FDA Approval Summary: Fam-Trastuzumab Deruxtecan-Nxki for the Treatment of Unresectable or Metastatic HER2-Positive Breast Cancer. Clinical Cancer Research. 27(16). 4478–4485. 118 indexed citations
4.
Natori, Yoichiro, Salma AlBahrani, Edwin C.Y. Chow, et al.. (2018). Risk factors for surgical site infection after kidney and pancreas transplantation. Infection Control and Hospital Epidemiology. 39(9). 1042–1048. 11 indexed citations
5.
Chow, Edwin C.Y., et al.. (2017). Highlighting Vitamin D Receptor–Targeted Activities of 1α,25-Dihydroxyvitamin D3 in Mice via Physiologically Based Pharmacokinetic-Pharmacodynamic Modeling. Drug Metabolism and Disposition. 46(1). 75–87. 12 indexed citations
7.
Chow, Edwin C.Y., Jianyao Wang, Hui Tang, et al.. (2016). Functional Integrity of the Chimeric (Humanized) Mouse Liver: Enzyme Zonation, Physiologic Spaces, and Hepatic Enzymes and Transporters. Drug Metabolism and Disposition. 44(9). 1524–1535. 9 indexed citations
8.
Chow, Edwin C.Y., Arjang Talattof, Eleftheria Tsakalozou, et al.. (2016). Using Physiologically Based Pharmacokinetic (PBPK) Modeling to Evaluate the Impact of Pharmaceutical Excipients on Oral Drug Absorption: Sensitivity Analyses. The AAPS Journal. 18(6). 1500–1511. 26 indexed citations
9.
Chow, Edwin C.Y., Yueping Zhang, David C. Evans, et al.. (2016). Disrupted Murine Gut–to–Human Liver Signaling Alters Bile Acid Homeostasis in Humanized Mouse Liver Models. Journal of Pharmacology and Experimental Therapeutics. 360(1). 174–191. 21 indexed citations
11.
Chow, Edwin C.Y., Lilia Magomedova, Rucha Patel, et al.. (2013). Vitamin D Receptor Activation Down-regulates the Small Heterodimer Partner and Increases CYP7A1 to Lower Cholesterol. Gastroenterology. 146(4). 1048–1059.e7. 76 indexed citations
12.
Chow, Edwin C.Y., Matthew R. Durk, Carolyn L. Cummins, & K. Sandy Pang. (2011). 1α,25-Dihydroxyvitamin D3 Up-Regulates P-Glycoprotein via the Vitamin D Receptor and Not Farnesoid X Receptor in Both fxr(−/−) and fxr(+/+) Mice and Increased Renal and Brain Efflux of Digoxin in Mice In Vivo. Journal of Pharmacology and Experimental Therapeutics. 337(3). 846–859. 64 indexed citations
13.
Khan, Ansar A., Edwin C.Y. Chow, Robert J. Porte, K. Sandy Pang, & Geny M. M. Groothuis. (2010). The role of lithocholic acid in the regulation of bile acid detoxication, synthesis, and transport proteins in rat and human intestine and liver slices. Toxicology in Vitro. 25(1). 80–90. 28 indexed citations
14.
Khan, Ansar A., et al.. (2009). Comparison of effects of VDR versus PXR, FXR and GR ligands on the regulation of CYP3A isozymes in rat and human intestine and liver. European Journal of Pharmaceutical Sciences. 37(2). 115–125. 68 indexed citations
15.
Chow, Edwin C.Y., Huadong Sun, Ansar A. Khan, Geny M. M. Groothuis, & K. Sandy Pang. (2009). Effects of 1α,25‐dihydroxyvitamin D3on transporters and enzymes of the rat intestine and kidneyin vivo. Biopharmaceutics & Drug Disposition. 31(1). 91–108. 57 indexed citations
16.
Khan, Ansar A., Edwin C.Y. Chow, Robert J. Porte, K. Sandy Pang, & Geny M. M. Groothuis. (2009). Expression and regulation of the bile acid transporter, OSTα‐OSTβ in rat and human intestine and liver. Biopharmaceutics & Drug Disposition. 30(5). 241–258. 30 indexed citations
17.
Chow, Edwin C.Y., et al.. (2008). Role of Haptoglobin on the Uptake of Native and β-Chain [Trimesoyl-(Lys82)β-(Lys82)β] Cross-Linked Human Hemoglobins in Isolated Perfused Rat Livers. Drug Metabolism and Disposition. 36(5). 937–945. 10 indexed citations
18.
Chen, Yan, Heather Whetstone, Puviindran Nadesan, et al.. (2006). β-Catenin Signaling Pathway Is Crucial for Bone Morphogenetic Protein 2 to Induce New Bone Formation. Journal of Biological Chemistry. 282(1). 526–533. 162 indexed citations
19.
Huizinga, Jan D., I. Berezin, Edwin E. Daniel, & Edwin C.Y. Chow. (1990). Inhibitory innervation of colonic smooth muscle cells and interstitial cells of Cajal. Canadian Journal of Physiology and Pharmacology. 68(3). 447–454. 45 indexed citations
20.
Huizinga, Jan D., et al.. (1988). Relationship between transmural potential difference and smooth muscle slow waves and contractility in the rabbit small intestine in vitro. Canadian Journal of Physiology and Pharmacology. 66(9). 1161–1165. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026